New Androgen Receptor Chemicals

Catalog No.	Product Name	Information
E6489	AZD9750	AZD9750 is an orally bioavailable, CRBN-recruiting androgen receptor PROTAC degrader that induces proteasome-dependent degradation of wild-type AR and resistant AR mutants, inhibits AR signaling, and suppresses prostate cancer xenograft tumor growth in vivo.
E1233	Rezvilutamide	Rezvilutamide (SHR3680) is an orally bioavailable and second-generation antagonist of androgen receptor (AR) that competitively binds to androgen receptors, preventing receptor activation and blocking the transcription of genes that fuel prostate cancer cell proliferation.
≡ All Androgen Receptor Chemicals